Results

Total Results: over 10,000 records

Showing results for "drugs".

201. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards
     March 09, 2010 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … Research Protocol Archived The Effectiveness of Disease-Modifying Antirheumatic Drugs … September 26, 2011 Systematic Review Archived Disease-Modifying Antirheumatic Drugs

202. STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and Older, U.S. Civilian Noninstitutionalized Population, 2009
     meps.ahrq.gov/data_files/publications/st362/draft/stat362.shtml
     March 01, 2012 - STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs … STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs … Anita Soni, PhD Highlights In 2009, the top five therapeutic classes of prescription drugs … Findings In 2009, the top five therapeutic classes of prescribed drugs purchased by adults age 18 … Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and

203. STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and Older, U.S. Civilian Noninstitutionalized Population, 2009
     meps.ahrq.gov/data_files/publications/st362/stat362.shtml
     March 01, 2012 - STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs … STATISTICAL BRIEF #362: Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs … Anita Soni, PhD Highlights In 2009, the top five therapeutic classes of prescription drugs … Findings In 2009, the top five therapeutic classes of prescribed drugs purchased by adults age 18 and … Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Adults Age 18 and

204. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/46970/psn-pdf
     June 27, 2018 - Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound- alike-drugs … Look-alike, sound-alike drugs are a known safety risk and contribute to medication errors. … psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound-alike-drugs

205. Sb271
     meps.ahrq.gov/data_files/publications/st271/sb271.xml
     December 01, 2009 - STATISTICAL BRIEF #271 December 2009 Trends in Outpatient Prescription Thyroid Drugs Purchases … Stagnitti, MPA Highlights From 1996 to 2007, total expenditures for prescription thyroid drugs … When comparing 1996 and 2007, the total number of prescription purchases of thyroid drugs for adults … were included in the therapeutic subclass thyroid drugs. … of drugs.

206. STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs Utilization and Expenditures for Adult Women in the U.S. Civilian Noninstitutionalized Population, 2001-2008
     meps.ahrq.gov/data_files/publications/st347/draft/stat347.shtml
     November 01, 2011 - STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs Utilization and Expenditures …   STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs … 2008, inflation adjusted total expenditures for outpatient prescription hormone replacement therapy drugs … Between 2001 and 2008 utilization of outpatient prescription hormone replacement therapy drugs by adult … the number of adult women obtaining one or more outpatient prescription hormone replacement therapy drugs

207. STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs Utilization and Expenditures for Adult Women in the U.S. Civilian Noninstitutionalized Population, 2001-2008
     meps.ahrq.gov/data_files/publications/st347/stat347.shtml
     November 01, 2011 - STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs Utilization and Expenditures …   STATISTICAL BRIEF #347: Trends in Hormone Replacement Therapy Drugs … 2008, inflation adjusted total expenditures for outpatient prescription hormone replacement therapy drugs … Between 2001 and 2008 utilization of outpatient prescription hormone replacement therapy drugs by adult … the number of adult women obtaining one or more outpatient prescription hormone replacement therapy drugs

208. Migraine-Adults-Executive-130408 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
     April 01, 2013 - or approved versus off-label drugs. … Discussion All approved drugs, some off-label beta blockers, and the angiotensin inhibiting drugs were … The relative effect size of drugs was moderate: drugs would result in to 200 to 400 cases of clinical … or approved versus off-label drugs. … Modeling choice behavior for new pharmaceutical products.

209. Migraine-Adults-Executive-130408 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
     April 01, 2013 - or approved versus off-label drugs. … Discussion All approved drugs, some off-label beta blockers, and the angiotensin inhibiting drugs were … The relative effect size of drugs was moderate: drugs would result in to 200 to 400 cases of clinical … or approved versus off-label drugs. … Modeling choice behavior for new pharmaceutical products.

210. Appendix 247 - Opioid-Related Hospital Stays Among Women in the United States, 2016 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb247-appendix.pdf
     January 14, 2019 - by sulfonamides, intentional self-harm, initial encounter T37.1X2A Poisoning by antimycobacterial drugs … , intentional self-harm, initial encounter T37.2X2A Poisoning by antimalarials and drugs acting on … blood protozoa, intentional self-harm, initial encounter T37.3X2A Poisoning by other antiprotozoal drugs … , intentional self-harm, initial encounter T38.3X2A Poisoning by insulin and oral hypoglycemic drugs … acting on muscles, intentional self-harm, initial encounter T48.292A Poisoning by other drugs acting

211. Final Report: Improving Drug Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
     January 01, 2024 - chronic renal insufficiency (Renal Intervention); b) lab monitoring of patients receiving high-risk drugs … Lab monitoring of patients receiving high-risk drugs (Lab Monitoring Intervention) c. … There were 20,000+ patients prescribed high-risk drugs that required lab monitoring. … at risk of having these drugs accumulate, with resulting increases in risk of drug toxicity. … combinations, spironolactone), whereas some low-yield drugs were removed.

212. NDC | Digital Healthcare Research
     digital.ahrq.gov/ndc
     January 01, 2023 - are ambiguous; many NDCs can exist for a single product, leading to inaccuracies in the dispensing of drugs … Library of Medicine (NLM) has been working on RxNorm , which provides "standard names for clinical drugs … Background The National Drug Codes (NDCs) are standards for reporting drugs and biological products … The Drug Listing Act of 1972 requires that all drug-producing establishments report to the FDA all drugs … Only selected non-prescription drugs are included in the NDC database.

213. Change Log (v2024.1 to v2025.1) for the HCUP Chronic Condition Indicator Refined (CCIR) for ICD-10-CM (xls file)
     hcup-us.ahrq.gov/toolssoftware/chronic_icd10/CCIR-ChangeLog-v20241-v20251.xlsx
     November 01, 2024 - R4185 Anosognosia 1 Chronic T45AX1A Poisoning by immune checkpoint inhibitors and immunostimulant drugs … , sequela 0 Not chronic T45AX5A Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … encounter 0 Not chronic T45AX5D Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … encounter 0 Not chronic T45AX5S Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … , sequela 0 Not chronic T45AX6A Underdosing of immune checkpoint inhibitors and immunostimulant drugs

214. Statistical Brief #407: Trends in Utilization and Expenditures of Prescribed Drugs Treating Diabetes, Hypertension, and High Cholesterol for Persons under Age 40 in the U.S. Civilian Noninstitutionalized Population, 2000 and 2010 (pdf file)
     meps.ahrq.gov/data_files/publications/st407/stat407.pdf
     June 01, 2013 - Statistical Brief #407: Trends in Utilization and Expenditures of Prescribed Drugs Treating Diabetes, … and 2010 1 STATISTICAL BRIEF #407 June 2013 Trends in Utilization and Expenditures of Prescribed Drugs … drugs become available. … Trends in Utilization and Expenditures of Prescribed Drugs Treating Diabetes, Hypertension, and High … Total number of prescribed drug purchases of anti-diabetic, anti-hypertensive, or statin drugs for

215. Origin of Adverse Drug Events in U.S. Hospitals, 2011 - Statistical Brief #158
     hcup-us.ahrq.gov/reports/statbriefs/sb158.jsp
     July 01, 2013 - system drugs 2.6 0.7 0.7 0.5 Cardiovascular drugs 29.4 7.6 7.5 5.8 Digoxin … 21.4 16.6 Abbreviation: NSAIDS, nonsteroidal anti-inflammatory drugs. … Cardiovascular drugs: 7.5 originated during the stay and 29.4 were present on admission. … Antidepressants, 17.6, Central nervous system drugs, 13.5, Other psychotropic drugs, 9.5, Insulin and … drugs, 5.5.

216. Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006-2019. | PSNet
     psnet.ahrq.gov/issue/nearly-all-thirty-most-frequently-used-emergency-department-drugs-experienced-shortages-2006
     April 27, 2022 - Study Nearly all thirty most frequently used emergency department drugs experienced … Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006–2019 … Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006–2019 … September 5, 2018 Despite federal legislation, shortages of drugs used in acute care

217. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
     January 01, 2009 - Results of Topic Selection Process & Next Steps  Generic versus brand name antiepileptic drugs … come out against the substitution of „A‟ rated generics, and neurologists use a large amount of brand drugs … In addition, many states include these drugs in their narrow therapeutic index laws. … : All patients with seizures stratified by seizure type Intervention(s): Brand name antiepileptic drugs … Comparator(s): Generic antiepileptic drugs Outcome(s): Seizure control, emergency department visits

218. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
     January 01, 2009 - Results of Topic Selection Process & Next Steps  Generic versus brand name antiepileptic drugs … come out against the substitution of „A‟ rated generics, and neurologists use a large amount of brand drugs … In addition, many states include these drugs in their narrow therapeutic index laws. … : All patients with seizures stratified by seizure type Intervention(s): Brand name antiepileptic drugs … Comparator(s): Generic antiepileptic drugs Outcome(s): Seizure control, emergency department visits

219. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/37975/psn-pdf
     February 15, 2011 - A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. … A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. … https://psnet.ahrq.gov/issue/steep-increase-domestic-fatal-medication-errors-use-alcohol-andor-street- drugs … https://psnet.ahrq.gov/issue/steep-increase-domestic-fatal-medication-errors-use-alcohol-andor-street-drugs … https://psnet.ahrq.gov/issue/steep-increase-domestic-fatal-medication-errors-use-alcohol-andor-street-drugs

220. Canada Uses AHRQ Research to Prevent Medication Errors | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/cquips0701.html
     October 01, 2014 - AHRQ-supported research was influential in revisions to Health Canada's process for approving names for drugs … A drug neighborhood is a group of drugs with similar spellings, pronunciations, or therapeutic uses that … An example of a confusing (or "dense") neighborhood of drugs includes Dynabac, Synalar, Rynatan, Dynacirc … An example of a less confusing (or low density) neighborhood of drugs is the one containing only Flexeril … Notably, commonly prescribed drugs are recognized more accurately than rarely prescribed ones.